Results 251 to 260 of about 40,520,256 (406)
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh+5 more
wiley +1 more source
Defining 'liaison haematology' in the UK: a modified Delphi study. [PDF]
Ransome N+6 more
europepmc +1 more source
Pericytes change function depending on glioblastoma vicinity: emphasis on immune regulation
Pericytes alter their transcriptome depending on their proximity to the tumor core. In the tumor core, pericytes display a more active state with higher communication strength but with lower immune activation potential and a shift toward extracellular matrix production.
Carolina Buizza+5 more
wiley +1 more source
Dis/Art, (This) Labour Transfiguration in the Age of Precarity and Disposability
Bruno Gulli
doaj
Associations Between Work-Related Factors, Mental Well-Being, and Health Literacy Sensitivity: A Cross-Sectional Study Among Healthcare Personnel. [PDF]
Stavdal MN+8 more
europepmc +1 more source
Oxygen Tension as a Factor in Meiosis Preliminary exploratory work
James C. Cross
openalex +2 more sources
Work, more work and retirement: Older Workers' Perspectives [PDF]
Loretto, Wendy, White, Phil
core +1 more source
RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha+10 more
wiley +1 more source